IBP(IBP)
IBP
Q4 2026 EPS Estimate
$2.87
Nov 4, 2026 · Reports before open
Revenue Estimate
$791M
FY2026E EPS$10.04
FY2027E EPS$11.21
Analyst Sentiment
Wall St. Consensus
Hold24 analysts·High coverage
59
Score
10 Buy (42%)13 Hold (54%)1 Sell (4%)
Rating Breakdown
Strong Buy
00%
Buy
1042%
Hold
1354%
Sell
14%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$200.00
-16.7%
Consensus
$242.00
+0.7%
Bull
$250.00
+4.1%
12-Month Target Range24 analysts
$200.00$242.00$250.00
Current $240.23Consensus
Current Price
$240.23
Upside to Consensus
$1.77
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+4.70%
EPS+11.62%
FY2028
Rev+6.82%
EPS+18.50%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $2.95B | $3.09B | $3.30B |
| Low | $2.90B | $2.97B | $3.22B |
| High | $3.01B | $3.20B | $3.42B |
| EBITDA Avg | $628M | $658M | $703M |
| Low | $617M | $632M | $685M |
| High | $641M | $682M | $728M |
| EBIT Avg | $492M | $515M | $550M |
| Low | $483M | $494M | $536M |
| High | $502M | $534M | $570M |
| Net Income Avg | $270M | $303M | $357M |
| Low | $269M | $299M | $342M |
| High | $274M | $307M | $373M |
| EPS Avg | $10.04 | $11.21 | $13.28 |
| Low | $9.94 | $11.06 | $12.64 |
| High | $10.13 | $11.35 | $13.80 |
| Analysts (Rev / EPS) | 8 / 6 | 9 / 6 | 3 / 3 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $782M | $764M | $705M | $785M | $825M | $799M | $735M | $811M |
| Low | $768M | $713M | $679M | $756M | $794M | $769M | $708M | $781M |
| High | $797M | $785M | $721M | $803M | $844M | $817M | $752M | $829M |
| EBITDA Avg | $167M | $163M | $150M | $167M | $176M | $170M | $157M | $173M |
| Low | $163M | $152M | $145M | $161M | $169M | $164M | $151M | $166M |
| High | $170M | $167M | $154M | $171M | $180M | $174M | $160M | $177M |
| EBIT Avg | $130M | $127M | $118M | $131M | $138M | $133M | $123M | $135M |
| Low | $128M | $119M | $113M | $126M | $132M | $128M | $118M | $130M |
| High | $133M | $131M | $120M | $134M | $141M | $136M | $125M | $138M |
| Net Income Avg | $77M | $76M | $55M | $73M | $85M | $84M | $63M | $86M |
| Low | $73M | $68M | $53M | $70M | $81M | $80M | $60M | $82M |
| High | $79M | $82M | $57M | $75M | $87M | $86M | $65M | $88M |
| EPS Avg | $2.86 | $2.85 | $2.07 | $2.74 | $3.18 | $3.13 | $2.37 | $3.21 |
| Low | $2.72 | $2.55 | $1.97 | $2.61 | $3.02 | $2.98 | $2.25 | $3.06 |
| High | $2.95 | $3.06 | $2.13 | $2.82 | $3.27 | $3.22 | $2.44 | $3.31 |
| Analysts (Rev / EPS) | 7 / 7 | 12 / 13 | 6 / 5 | 6 / 5 | 6 / 5 | 6 / 5 | 5 / 6 | 5 / 6 |